Atlas Molecular Pharma
PrivateLast Round
Grant
Jun 17, 2025
Total Funding Raised
$2.5M
Company Overview
Atlas Molecular Pharma operates in Healthcare & Life Sciences and is based in Derio. Its latest recorded funding round was a Grant round in June 2025.
Atlas Molecular Pharma is a biotechnology company that discovers and develops first-in-class, innovative therapeutics for the treatment of rare and ultra-rare diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting, Government Contracts
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Atlas Molecular Pharma Comparables
Compare Atlas Molecular Pharma with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Protego Biopharma | 82% | |
| Pluvia Biotech | 81% | |
| Stablix | 78% |
For institutional investors. Book with your work email.
Atlas Molecular Pharma Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jun 17, 2025 | ||||
| VC Round | Feb 2, 2022 | ||||
| Seed | Sep 13, 2016 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Atlas Molecular Pharma Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Inveready | VC Round |
| Center for Technological Development and Innovation | VC Round |
| CRB Health Tech | VC Round, Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 24, 2026
Monthly visitors grew 34% MoM, reaching 1.4K.
- Feb 23, 2026
Grew 57% QoQ from 7 to 11 employees.
For institutional investors. Book with your work email.
Atlas Molecular Pharma Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Atlas Molecular Pharma's valuation, stock price, and market status.
Is Atlas Molecular Pharma a public or private company?
Atlas Molecular Pharma is a private company.
What is the current stock price of Atlas Molecular Pharma?
Atlas Molecular Pharma is a private company, so its shares have no public market price. Caplight tracks Atlas Molecular Pharma's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Atlas Molecular Pharma worth (valuation)?
Valuation information for Atlas Molecular Pharma is not publicly available.
Can I buy Atlas Molecular Pharma stock?
Atlas Molecular Pharma shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Atlas Molecular Pharma's last funding round?
Atlas Molecular Pharma's most recent funding round was Grant on June 17, 2025.
Who are the main investors in Atlas Molecular Pharma?
Key investors in Atlas Molecular Pharma include Inveready.
Will Atlas Molecular Pharma IPO soon?
No public IPO plans have been announced for Atlas Molecular Pharma.
How can I track Atlas Molecular Pharma secondary market activity?
Caplight tracks bids, offers, and trades in Atlas Molecular Pharma's shares on secondary markets.